We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.
$15.00 - $17.00
November 6, 2019
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,LEERINK SWANN & COMPANY
To view the prospectus for 89bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253